Cel-Sci Corporation
Records under this name other than the patents Cel-Sci Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,041,013 | Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis Lapsed on the fee record Ended Jun 22, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 22, 2025 | From the USPTO record |
| US 6,896,879 | Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture Term ended Term ended Sep 2, 2023 · From the USPTO record | Term ended | Term ended Sep 2, 2023 | From the USPTO record |
| US 7,199,216 | Peptide constructs for treating autoimmune and related diseases Term ended Term ended Jul 13, 2022 · From the USPTO record | Term ended | Term ended Jul 13, 2022 | From the USPTO record |
| US 6,995,237 | Preparation and Composition of Peptides Useful for Treatment of Autoimmune and Transplant Related Graft Versus Host Conditions Term ended Term ended Sep 17, 2021 · High confidence | Term ended | Term ended Sep 17, 2021 | High confidence |
| US 7,256,254 | Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions Term ended Ended no later than Oct 27, 2020 · From the USPTO record | Term ended | Ended no later than Oct 27, 2020 | From the USPTO record |
| US 6,096,315 | Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same Lapsed on the fee record Ended Aug 1, 2012 · From the USPTO record | Lapsed on the fee record | Ended Aug 1, 2012 | From the USPTO record |
| US 6,572,860 | Immunogenic conjugated polypeptide for treatment of herpes simplex virus Lapsed on the fee record Ended Jun 3, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jun 3, 2011 | From the USPTO record |
| US 6,951,647 | T cell binding ligand peptides and method of inducing a cellular immune response Lapsed on the fee record Ended Oct 4, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2009 | From the USPTO record |
| US 6,287,565 | Modified HGP-30 heteroconjugates, compositions and methods of use Lapsed on the fee record Ended Sep 11, 2005 · From the USPTO record | Lapsed on the fee record | Ended Sep 11, 2005 | From the USPTO record |
| US 6,268,472 | Modified HGP-30 peptides, conjugates, compositions and methods of use Lapsed on the fee record Ended Jul 31, 2005 · From the USPTO record | Lapsed on the fee record | Ended Jul 31, 2005 | From the USPTO record |